Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ives

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Adjuvant interferon for melanomaK Wheatley, N Ives
Immunological Investigations|February 1, 1991
Effect of anti-Ig on rabbit B cell function and Ig expressionN Ives, V Asundi, K Dreher
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Role of entacapone in later Parkinson's disease not yet establishedK Wheatley, N Ives, R Gray, et al.
Anaesthesia|February 15, 2000
Risk factors for pressure sores in the critically illC Theaker, M Mannan, N Ives, et al.
Life Sciences|October 14, 1985
Naloxone inhibits superoxide release from human neutrophilsC O Simpkins, N Ives, E Tate, et al.
The Cochrane Database of Systematic Reviews|July 22, 2005
Monoamine oxidase B inhibitors for early Parkinson's diseaseA D Macleod, C E Counsell, N Ives, et al.
European Journal of Pharmacology|November 4, 1986
BAY k 8644, a calcium channel agonist, reverses hypotension in endotoxin-shocked ratsN Ives, J W King, B Chernow, et al.
The Journal of Infection|July 1, 1987
A novel presentation of Coxsackie B2 virus infection during pregnancyR G Feldman, J Bryant, K N Ives, et al.
Lancet (London, England)|October 30, 1982
Serratia marcescens pseudobacteremia on a special care baby unitK N Ives, N A Evans, B T Thom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimensP J Easterbrook, R Newson, N Ives, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
Adjuvant interferon for melanomaK Wheatley, N Ives
Immunological Investigations|February 1, 1991
Effect of anti-Ig on rabbit B cell function and Ig expressionN Ives, V Asundi, K Dreher
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Role of entacapone in later Parkinson's disease not yet establishedK Wheatley, N Ives, R Gray, et al.
Anaesthesia|February 15, 2000
Risk factors for pressure sores in the critically illC Theaker, M Mannan, N Ives, et al.
Life Sciences|October 14, 1985
Naloxone inhibits superoxide release from human neutrophilsC O Simpkins, N Ives, E Tate, et al.
The Cochrane Database of Systematic Reviews|July 22, 2005
Monoamine oxidase B inhibitors for early Parkinson's diseaseA D Macleod, C E Counsell, N Ives, et al.
European Journal of Pharmacology|November 4, 1986
BAY k 8644, a calcium channel agonist, reverses hypotension in endotoxin-shocked ratsN Ives, J W King, B Chernow, et al.
The Journal of Infection|July 1, 1987
A novel presentation of Coxsackie B2 virus infection during pregnancyR G Feldman, J Bryant, K N Ives, et al.
Lancet (London, England)|October 30, 1982
Serratia marcescens pseudobacteremia on a special care baby unitK N Ives, N A Evans, B T Thom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimensP J Easterbrook, R Newson, N Ives, et al.
Pageof 4